期刊文献+

p53,Ki67,GST-π和MDR-1在卵巢上皮性肿瘤中的表达及意义

The Expression and Significance of p53,Ki67,GST-π and MDR-1 Protein in Epithelial Ovarian Tumors
原文传递
导出
摘要 目的研究抑癌基因蛋白p53、细胞核增殖相关抗原Ki67、耐药基因谷胱甘肽S-转移酶-pi(GST-π)和多药耐药基因MDR-1在卵巢上皮性肿瘤组织中的表达,探讨其表达与卵巢癌临床病理参数及预后的相关性。方法应用免疫组化法检测20例良性肿瘤,20例交界性肿瘤及108例卵巢上皮性癌的卵巢肿瘤组织p53、Ki67、GST-π和MDR-1的表达情况。结果 p53、Ki67、GST-π和MDR-1卵巢交界性肿瘤及上皮性癌中的阳性表达率明显高于良性肿瘤(P<0.01),p53与Ki67之间、Ki67与GST-π之间相关系数差异有统计学意义(P<0.01)。p53蛋白表达与卵巢癌组织分化程度相关系数差异有统计学意义(P<0.01);Ki67与组织分化程度、病理类型及CA125水平相关系数差异有统计学意义(P<0.05),GST-π及MDR-1与卵巢癌临床病理参数相关系数差异无统计学意义(P>0.05)。p53阳性表达患者的无瘤生存时间及总生存时间明显低于p53阴性表达患者(P<0.05),多因素回归显示p53阳性表达可作为预测卵巢癌无瘤生存预后的独立因素(P<0.05)。结论p53、Ki67、GST-π和MDR-1蛋白阳性表达与卵巢癌的发生发展有密切关系,p53可作为预测卵巢癌预后的重要因素。 Objective To explore expression level of p53,Ki67,GST-π and MDR-1 protein in epithelial ovarian tumors and its correlation with clinicopathological parameters and prognosis of epithelial ovarian tumors.Methods Immunohistochemical method was used to detect the expression level of p53,Ki67,GST-π and MDR-1 protein in 148 tumor tissues including 20 benign tumors,20 borderline tumors and 108 epithelial ovarian tumors.Results The positive rates of p53,Ki67,GST-π and MDR-1 in borderline and malignant tumors were higher than those in benign tumors(P<0.01).Significant correlations were observed between p53 and Ki67(P<0.01),so did Ki67 and GST-π(P<0.01).The expression of p53 in ovarian cancer was correlated with histological grade(P<0.01),and expression of Ki67 protein was correlated with histological grade,histological type and CA125 level(all P<0.05).There was no significant relationship between the expression of GST-π,MDR-1 and clinicopathological parameters(P>0.05).Patients with positive expression of p53 demonstrated a significantly worse prognosis than that of patients with negative p53 expression for disease-free survival time and overall survival time(both P<0.05).It was revealed by multivariate regression analysis that the positive expression rate of p53 could be an independent factor for predicting the disease-free survival time of epithelial ovarian tumors(P<0.05).Conclusion The expression of p53,Ki67,GST-π and MDR-1 protein was significantly associated with the development and progression of epithelial ovarian cancer.p53 may be an important prognostic factor for survival of patients with epithelial ovarian cancer.
出处 《浙江预防医学》 2013年第5期1-4,8,共5页 Zhejiang Journal of Preventive Medicine
关键词 卵巢肿瘤 P53 KI67 GST-Π MDR-1 Ovarian neoplasms p53 Ki67 GST-π MDR-1 Expression
  • 相关文献

参考文献12

  • 1JemalA,Siegel R,XuJ. Cancer statistics,2010[J].CA:A Cancer Journal for Clinicians,2010,(05):277-300.
  • 2崔珅,姬宏飞,王贝,韩世愈.卵巢上皮性癌BRCA1、p53及Ki67蛋白表达与生存时间相关性研究[J].实用肿瘤学杂志,2009,23(2):134-138. 被引量:3
  • 3Therasse P;Arbuck SG;Eisenhauer EA.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada,2000.
  • 4王承红.p53基因在肿瘤放疗中的研究进展[J].医学综述,2010,16(2):205-207. 被引量:19
  • 5Ecke TH,Schlechte HH,Schiemenz K. TP53 gene mutations in prostate cancer progression[J].Anticancer Research,2010,(05):1579-1586.
  • 6Baker L,Quinlan PR,Patten N. p53 mutation,deprivation and poor prognosis in primary breast cancer[J].British Journal of Cancer,2010,(04):719-726.
  • 7Kim K,Chic EK,Han W. Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy[J].Journal of Korean Medical Science,2010,(02):235-239.
  • 8Yerushalmi R,Woods R,Ravdin PM. Ki67 in breast cancer:prognostic and predictive potential[J].Lancet Oncology,2010,(02):174-183.
  • 9Arshad H,Ahmad Z,Hasan SH. Gliomas:correlation of histologic grade,Ki67 and p53 expression with patient survival[J].Asian Pacific Journal of Cancer Prevention,2010,(06):1637-1640.
  • 10Gonul Ⅱ,Akyurek N,Dursun A. Relationship of Ki67,TP53,MDM~-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades,tumor category and overall patient survival in urothelial tumors of the bladder[J].Pathology Research and Practice,2008,(10):707-717.

二级参考文献27

  • 1张珊文,肖绍文,杨敬贤.腺病毒介导p53基因转染增加人胃癌细胞的放射敏感性[J].中华放射医学与防护杂志,2004,24(4):308-311. 被引量:10
  • 2刘秀芳,夏云飞,李满枝,贺玉香,郑美莲,蒋昌斌.不同p53功能状态鼻咽癌细胞株的放射生物学特性[J].中华放射肿瘤学杂志,2005,14(4):335-338. 被引量:8
  • 3冯艳,李彩霞.p53基因与肝癌[J].医学影像学杂志,2006,16(10):1105-1107. 被引量:3
  • 4郜文秀,丰建国,杨艳芳,梁小波,李耀平,李佩珍.增殖细胞核抗原在大肠癌中的表达及预后[J].现代预防医学,2007,34(2):225-226. 被引量:8
  • 5王峰(综述),王建华(综述),许锡元(审校).p53基因增加肿瘤放射治疗敏感性的机制[J].国际肿瘤学杂志,2007,34(5):342-344. 被引量:10
  • 6Miki Y, Swensen J, Shattuck ED, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 [ J]. Science, 1994,266 (5182) :66 - 71.
  • 7Ford D. Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [ J ]. Am J Hum Genet, 1998,62 : 676 - 689.
  • 8Gretarsdottir S, Thorlacius S, Valgardsdottir R, et al. BRCA2 and p53 mutation in primary breast cancer in relation to genetic instability [ J ]. Cancer Research, 1998,58 (5) :859.
  • 9Milner B J, Allan LA, Eccles DM, et al. p53 mutation is a common genetic event in ovarian carcinoma [ J ]. Cancer Res. 1993.53:2128 - 2132.
  • 10Soslow RA, Shen PU, Chung MH, et al. Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma[ J]. Int J Gynecol Pathol, 1998,17 : 129 - 134.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部